53 related articles for article (PubMed ID: 12699880)
1. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
2. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.
Catherino WH; Leppert PC; Stenmark MH; Payson M; Potlog-Nahari C; Nieman LK; Segars JH
Genes Chromosomes Cancer; 2004 Jul; 40(3):204-17. PubMed ID: 15139000
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Synaptic Signaling Genes Is Involved in Biology of Uterine Leiomyoma.
Krsteski J; Gorenjak M; But I; Pakiž M; Potočnik U
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440356
[TBL] [Abstract][Full Text] [Related]
5. The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.
Luo X; Chegini N
Semin Reprod Med; 2008 Nov; 26(6):500-14. PubMed ID: 18951332
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-X and leukemia inhibitory factor receptor are down-regulated in leiomyoma compared with normal myometrium.
Lee SO; Lee SY; Lee SR; Ju W; Kim SC
J Gynecol Oncol; 2008 Jun; 19(2):139-44. PubMed ID: 19471560
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan catabolism is dysregulated in leiomyomas.
Chuang TD; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma.
Chuang TD; Xie Y; Yan W; Khorram O
Fertil Steril; 2018 May; 109(5):919-929. PubMed ID: 29778390
[TBL] [Abstract][Full Text] [Related]
9. Uterine fibroids: current perspectives.
Khan AT; Shehmar M; Gupta JK
Int J Womens Health; 2014; 6():95-114. PubMed ID: 24511243
[TBL] [Abstract][Full Text] [Related]
10. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.
Tal R; Segars JH
Hum Reprod Update; 2014; 20(2):194-216. PubMed ID: 24077979
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.
Suzuki A; Kariya M; Matsumura N; Baba T; Yagi H; Mandai M; Konishi I; Fujii S
Med Mol Morphol; 2012 Dec; 45(4):214-21. PubMed ID: 23224600
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model.
Halder SK; Sharan C; Al-Hendy A
Biol Reprod; 2012 Apr; 86(4):116. PubMed ID: 22302692
[TBL] [Abstract][Full Text] [Related]
13. Towards non-surgical therapy for uterine fibroids: catechol-O-methyl transferase inhibitor shrinks uterine fibroid lesions in the Eker rat model.
Hassan MH; Fouad H; Bahashwan S; Al-Hendy A
Hum Reprod; 2011 Nov; 26(11):3008-18. PubMed ID: 21896544
[TBL] [Abstract][Full Text] [Related]
14. Emerging Roles for SSeCKS/Gravin/AKAP12 in the Control of Cell Proliferation, Cancer Malignancy, and Barriergenesis.
Gelman IH
Genes Cancer; 2010 Nov; 1(11):1147-56. PubMed ID: 21779438
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone agonist increases expression of osmotic response genes in leiomyoma cells.
McCarthy-Keith DM; Malik M; Britten J; Segars J; Catherino WH
Fertil Steril; 2011 Jun; 95(7):2383-7. PubMed ID: 21496801
[TBL] [Abstract][Full Text] [Related]
16. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.
Zavadil J; Ye H; Liu Z; Wu J; Lee P; Hernando E; Soteropoulos P; Toruner GA; Wei JJ
PLoS One; 2010 Aug; 5(8):e12362. PubMed ID: 20808773
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.
Chegini N
Semin Reprod Med; 2010 May; 28(3):180-203. PubMed ID: 20414842
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas.
Bae SM; Kim YW; Lee JM; Namkoong SE; Kim CK; Ahn WS
Cancer Res Treat; 2004 Feb; 36(1):31-42. PubMed ID: 20396563
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.
Hassan MH; Salama SA; Zhang D; Arafa HM; Hamada FM; Fouad H; Walker CC; Al-Hendy A
Fertil Steril; 2010 Jan; 93(1):239-50. PubMed ID: 19144333
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.
Dimitrova IK; Richer JK; Rudolph MC; Spoelstra NS; Reno EM; Medina TM; Bradford AP
Fertil Steril; 2009 Jun; 91(6):2650-63. PubMed ID: 18672237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
